Nutriband Inc. (NTRB)
Automate Your Wheel Strategy on NTRB
With Tiblio's Option Bot, you can configure your own wheel strategy including NTRB - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol NTRB
- Rev/Share 0.2156
- Book/Share 0.4587
- PB 16.9844
- Debt/Equity 0.0553
- CurrentRatio 3.7079
- ROIC -1.1536
- MktCap 86891218.0
- FreeCF/Share -0.4688
- PFCF -16.6591
- PE -8.6906
- Debt/Assets 0.0459
- DivYield 0
- ROE -1.1325
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | NTRB | Noble Capital Markets | -- | Outperform | -- | $13 | Jan. 22, 2025 |
News
Nutriband Inc. (NTRB) Reports Q1 Loss, Misses Revenue Estimates
Published: May 30, 2025 by: Zacks Investment Research
Sentiment: Negative
Nutriband Inc. (NTRB) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.21 per share a year ago.
Read More
Nutriband CEO Publishes Letter to Shareholders
Published: April 30, 2025 by: GlobeNewsWire
Sentiment: Neutral
ORLANDO, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on achievements and milestones through 2024 and the potential outlook for 2025.
Read More
Nutriband Signs Partnership Agreement with Charlotte FC
Published: April 04, 2025 by: GlobeNewsWire
Sentiment: Neutral
ORLANDO, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it has signed an Associate Partnership agreement with Charlotte FC.
Read More
Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
Published: February 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange for milestone payments Nutriband is partnering with Kindeva Drug Delivery to develop Aversa™ Fentanyl which combines Nutriband's Aversa™ abuse-deterrent technology with Kindeva's FDA-approved fentanyl patch. ORLANDO, Fla.
Read More
About Nutriband Inc. (NTRB)
- IPO Date 2021-10-01
- Website https://nutriband.com
- Industry Biotechnology
- CEO Mr. Gareth Sheridan
- Employees 13